These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16801450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Epidemiological and molecular characterization of Staphylococcus haemolyticus strains, from a hematology ward, with decreased susceptibility to glycopeptides.
    Ma XX, Sun DD, Hu J, Wang EH, Luo EJ.
    Can J Microbiol; 2011 Jun; 57(6):476-84. PubMed ID: 21627487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
    Biavasco F, Vignaroli C, Lazzarini R, Varaldo PE.
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
    [Abstract] [Full Text] [Related]

  • 7. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
    Tabe Y, Nakamura A, Igari J.
    J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
    Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP.
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3861-70. PubMed ID: 20547791
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
    Bannerman TL, Wadiak DL, Kloos WE.
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
    [Abstract] [Full Text] [Related]

  • 16. Glycopeptide resistance in coagulase-negative staphylococci.
    Biavasco F, Vignaroli C, Varaldo PE.
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
    [Abstract] [Full Text] [Related]

  • 17. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW, Atoui R, Ben Ali A, Nguyen JC, Ly A, Kitzis MD.
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
    Chaudhury A, Kumar AG.
    Indian J Med Microbiol; 2007 Jan; 25(1):50-2. PubMed ID: 17377353
    [Abstract] [Full Text] [Related]

  • 19. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F, Giovanetti E, Montanari MP, Lupidi R, Varaldo PE.
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.